IIL.GSE is trading 10% up at $0.22 as it extends a multi-day rally from $0.16 despite a lack of fresh company-specific news or filings.
- The gain continues strong momentum observed since late June, likely driven by recent investor interest and low-liquidity price swings rather than fundamental triggers.
- The broader Ghana Stock Exchange is only modestly higher, suggesting the price action for Intravenous Infusions Limited is driven by idiosyncratic factors.